We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Caredx Inc
12 own
13 watching
Current Price
$7.96
$-0.13
(-1.61%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
426.12M
52-Week High
27.3498
52-Week Low
6.2202
Average Volume
0.52M
Dividend Yield
--
P/E Ratio
--
Market Capitalization426.12M52-Week High27.349852-Week Low6.2202Average Volume0.52MDividend Yield--P/E Ratio--What does the Caredx Inc do?
CareDx, Inc., a molecular diagnostics company, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in the United States and internationally. The company's commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection. It is also developing AlloSure, a next-generation sequencing-based test to detect donor-derived cell-free DNA after transplantation. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Read More
How much money does Caredx Inc make?
News & Events about Caredx Inc.
Globe Newswire
1month ago
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of LifeStance Health Group, Inc., Berry Corporation, CareDx, Inc., and Opendoor Technologies Inc. If you are a current owner of shares of any of these ...
Ticker Report
1month ago
CareDx, Inc (NASDAQ:CDNA Get Rating) insider Reginald Seeto sold 2,818 shares of the stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the transaction, the insider now owns 537,815 ...
Business Wire
2 months ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF continues its investigation into CareDx, Inc. (NasdaqGM: CDNA). In October 2021, the Company disclosed that it received a civil investigative...
Business Wire
2 months ago
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today commented on the release of a Billing Article related to MolDX Molecular Testing...
PR Newswire
3 months ago
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate...
Frequently Asked Questions
Frequently Asked Questions
What is Caredx Inc share price today?
Can Indians buy Caredx Inc shares?
How can I buy Caredx Inc shares from India?
Can Fractional shares of Caredx Inc be purchased?
What are the documents required to start investing in Caredx Inc stocks?
What is today’s traded volume of Caredx Inc?
What is today’s market capitalisation of Caredx Inc?
What is the 52-Week High and Low Range of Caredx Inc?
What percentage is Caredx Inc down from its 52-Week High?
What percentage is Caredx Inc up from its 52-Week Low?
Current Price
$7.96
$-0.13
(-1.61%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.